Marimed (MRMD) Interest Expenses (2012 - 2026)
Marimed (MRMD) posted quarterly Interest Expenses of $14.5 million for Q1 2026, up 566.73% year-over-year from $2.2 million in Q1 2025, and up 527.63% quarter-over-quarter from $2.3 million in Q4 2025.
Marimed (MRMD) Interest Expenses (2012 - 2026) Analysis & Trends
Marimed (MRMD) has reported Interest Expenses for 14 consecutive years, with $14.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 566.73% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $14.5 million (up 566.73% YoY), while the FY2025 annual figure was $7.5 million, down 58.63% from the prior year.
- Interest Expenses improved to $14.5 million in Q1 2026 per MRMD's latest filing, from $2.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $15.4 million in Q3 2025 and bottomed at -$8.1 million in Q1 2024.
- Historically, Interest Expenses has averaged $3.9 million across 5 years, with a median of $2.3 million in 2025.
- On a YoY basis, Interest Expenses climbed as much as 1074.48% in 2023 and fell as far as 444.71% in 2023.
- Marimed's Interest Expenses stood at $422000.0 in 2022, then jumped by 947.16% to $4.4 million in 2023, then tumbled by 59.54% to $1.8 million in 2024, then increased by 29.14% to $2.3 million in 2025, then jumped by 527.63% to $14.5 million in 2026.
- Business Quant data shows MRMD's Interest Expenses at $14.5 million in Q1 2026, $2.3 million in Q4 2025, and $15.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Marimed | 28.08 Mn | 17.74 Mn | 16.23 Mn | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.53 Mn |
| Jun 30, 2026 | 14.53 Mn |
| Mar 31, 2026 | 14.49 Mn |
| Mar 31, 2026 | 14.49 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Dec 31, 2025 | 2.31 Mn |
| Sep 30, 2025 | 15.41 Mn |
| Sep 30, 2025 | 15.41 Mn |
| Jun 30, 2025 | 4.06 Mn |
| Jun 30, 2025 | 4.06 Mn |
| Mar 31, 2025 | -3.11 Mn |
| Mar 31, 2025 | -3.11 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 10.19 Mn |
| Sep 30, 2024 | 10.19 Mn |
| Jun 30, 2024 | 10.68 Mn |
| Jun 30, 2024 | 10.68 Mn |
| Mar 31, 2024 | -8.14 Mn |
| Mar 31, 2024 | -8.14 Mn |